Scientific Advisory Board Member @ (August 2022 - September 2026)
VP, Drug Discovery @ (December 2019 - April 2021)
Director, Oncology Biotherapeutics @ (November 2016 - December 2019)
Director, Oncology Biotherapeutics @ (November 2016 - December 2019)
Lab Head, Oncology Biotherapeutics @ (November 2010 - November 2016)
Postdoctoral Fellow, Cancer Genetics @ (April 2007 - November 2010)
Carl Bialucha Education
MRC Laboratory for Molecular Cell Biology (LMCB), University College London
Ph.D. (Molecular Cell Biology)
2002-2007
University of California, San Francisco
Research Exchange Fellow (Cancer Genetics)
2003-2003
University of Sussex
BSc Hons (Molecular Genetics)
1999-2002
Carl Bialucha Skills
Antibodies
Assay Development
Biochemistry
Biomarker Discovery
Biotechnology
Cancer
Cell Biology
DNA
Drug Discovery
Genetics
Genomics
Life Sciences
Molecular Biology
Oncology
RNAi
Sequencing
Science
Project Management
Public Speaking
Customer Service
Research
Management
Carl Bialucha Summary
Carl Bialucha, based in Cambridge, MA, US, is currently a Chief Scientific Officer at Xilio Therapeutics, Inc.. Carl Bialucha brings experience from previous roles at Xilio Therapeutics, Inc., Terri Brodeur Breast Cancer Foundation (TBBCF) and Immunitas Therapeutics. Carl Bialucha holds a 2002 - 2007 Ph.D. in Molecular Cell Biology @ MRC Laboratory for Molecular Cell Biology (LMCB), University College London. With a robust skill set that includes Antibodies, Assay Development, Biochemistry, Biomarker Discovery, Biotechnology and more. Carl Bialucha has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Carl Bialucha?
Find contact details for 700 million professionals.